Amphotericin B — Drug Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

1 Completed trials

7 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase III/IV

Phase I (Other)

Phase III: 1 Phase II: 3 Phase I/II: 1 Phase III/IV: 1 Phase I (Other): 1

Indications tested

Aspergillus infection 1 Scedosporium infection 1 Inflammatory bowel disease 1 Fusarium infection 1 Fungal infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Basilea Pharmaceutica International AG Allschwil 1 Charite Universitaetsmedizin Berlin KöR 1 Fondazione Gimema Franco Mandelli Onlus 1 Pauls Stradins Clinical University Hospital 1 Radboud universitair medisch centrum Stichting 1 Stichting Radboud University Medical Center 1

All trials

7 total

The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending

2025-521770-34-00 Phase I (Other) 1 country Radboud universitair medisch centrum Stichting
A Phase 2, monocentric, prospective, nonrandomized, open-label, experimental study to evaluate efficacy and safety of intrabronchial instill… Pending

2025-523501-15-00 Phase II 1 country Pauls Stradins Clinical University Hospital
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Recruiting

2024-513330-38-00 Phase II 1 country Assistance Publique Hopitaux De Paris
PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized… Recruiting

2023-504144-33-01 Phase III/IV 2 countries Stichting Radboud University Medical Center
A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting

2024-514398-23-00 Phase I/II 1 country Charite Universitaetsmedizin Berlin KöR
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus

Showing 1–7 of 7 trials

← All drugs A–Z